Molina J-M, et al. Doravirine (DOR) versus ritonavir-boosted darunavir (DRV+r): 96-week results of the randomized, double-blind, phase 3 DRIVE-FORWARD Noninferiority trial. AIDS 2018.
VWS en GSK sluiten deal over H1N1-vaccin
mei 2010
jun 2024 | Niertransplantatie, Stamceltransplantatie, Virale infecties